HBE Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$348K Sell
290
-2
-0.7% -$2.04K 0.25% 40
2026
Q1
$269K Buy
292
+59
+25% +$59.8K 0.23% 43
2025
Q4
$250K Buy
+233
New +$223K 0.24% 40

Other funds holding LLY

HBE Wealth Management's LLY Position: Q2 2026 in Review

HBE Wealth Management reduced its Eli Lilly (LLY) stake by 0.68% in Q2 2026, selling an estimated $2.04K and leaving 290 shares worth $348K. The position accounts for 0.25% of the portfolio, ranked #40.

HBE Wealth Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • HBE Wealth Management held 290 shares of Eli Lilly worth $348K as of Q2 2026.
  • HBE Wealth Management sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.25% of HBE Wealth Management's portfolio in Q2 2026, its #40 holding.
  • HBE Wealth Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on HBE Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.